Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Professional Development

Reporting on Brain Health & Research: A Poynter Fellowship (2026-2027)

A sculptural brain model sits beside a blank notebook and pencil on a desk, with an open laptop in the background.

Reporting on Brain Health & Research: A Poynter Fellowship (2026-2027) is a prestigious, fully funded professional development opportunity for journalists, offering rare access to leading experts, personalized coaching and advanced training in brain health and brain science reporting. The listing is dated September 1, 2026, with an online location and Virtual as the city.

Hosted with: Psychedelic Writers Guild